Researchers at University of California San Diego School of Medicine found using blood thinners in patients with worsening heart failure, coronary artery disease and irregular heart rhythms was associated with a reduced risk of thromboembolic events, such as stroke and heart attack.
University of California San Diego School of Medicine researchers and collaborators describe a new set of “rules” that predict how the tissue of origin influences critical aspects of the genetic makeup of tumors, with potentially important therapeutic implications.
University of California San Diego School of Medicine researchers found that treating patients with personalized precision medicine that combined therapies to target multiple alterations improved outcomes in patients with therapy resistant cancers.
Susan Ackerman, Yishi Jin and John Wixted of UC San Diego have been elected to the American Academy of Arts and Sciences, one of the country’s most esteemed honorary societies and independent policy research centers. They will join 200 new members in the organization’s 2019 class.
UC San Diego Health has invested in a new robotic technology to benefit patients in need of restorative spine surgery. This technology enables minimally invasive spine surgery, the benefits of which include potential for shorter operations, less anesthesia, smaller incisions and reduced blood loss.
Treatment with a choline kinase inhibitor prompts immune cells to clear away damaged mitochondria, thus reducing NLRP3 inflammasome activation and preventing inflammation
The San Diego Union-Tribune, May 5
U.S. News & World Report, May 5
The New York Times, April 23
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
